loadpatents
Patent applications and USPTO patent grants for Tatton; William G..The latest application filed is for "methods for treating eye disorders".
Patent | Date |
---|---|
Methods for increasing schwann cell survival Grant 7,160,857 - Tatton , et al. January 9, 2 | 2007-01-09 |
Methods for treating eye disorders App 20050228054 - Tatton, William G. | 2005-10-13 |
Use of deprenyl compounds to treat viral infections and reduce tissue damage associated therewith App 20050222269 - Tatton, William G. ;   et al. | 2005-10-06 |
Methods for treating multiple sclerosis App 20050004229 - Shankar, L. Sai Latha ;   et al. | 2005-01-06 |
Use of deprenyl compounds to maintain, prevent loss, or recover nerve cell function App 20040180957 - Tatton, William G. ;   et al. | 2004-09-16 |
Deprenyl compounds for treatment of glaucoma App 20040176455 - Tatton, William G. | 2004-09-09 |
Treatment of dementia and parkinson's disease App 20040116436 - Tatton, William G. ;   et al. | 2004-06-17 |
Dehydrogenase oligomeric modulators App 20040086891 - Tatton, William G. ;   et al. | 2004-05-06 |
Deprenyl compounds for treatment of glaucoma App 20030139456 - Tatton, William G. | 2003-07-24 |
Method for treating multiple sclerosis App 20030078295 - Shankar, L. Sai Latha ;   et al. | 2003-04-24 |
Methods for increasing schwann cell survival App 20030004104 - Tatton, Nadine A. ;   et al. | 2003-01-02 |
Methods for treating multiple sclerosis Grant 6,492,427 - Shankar , et al. December 10, 2 | 2002-12-10 |
Deprenyl Compounds To Treat Viral Infections And Reduce Tissue Damage Associated Therewith App 20020137786 - TATTON, WILLIAM G. ;   et al. | 2002-09-26 |
Use of deprenyl compounds to maintain, prevent loss, or recover nerve cell function App 20020132829 - Tatton, William G. ;   et al. | 2002-09-19 |
Methods For Treating Multiple Sclerosis App 20020022661 - SHANKAR, SAI LATHA ;   et al. | 2002-02-21 |
Deprenyl compounds for treatment of glaucoma Grant 5,981,598 - Tatton November 9, 1 | 1999-11-09 |
Use of deprenyl compounds to maintain, prevent loss, or recover nerve cell function Grant 5,844,003 - Tatton , et al. December 1, 1 | 1998-12-01 |
Use of deprenyl to rescue damaged nerve cells Grant 5,444,095 - Tatton , et al. August 22, 1 | 1995-08-22 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.